How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

EULAR® 2024 Insights - Factors Associated with the Evolution of Dege…

EULAR® 2024 Insights

L. Pina Vegas

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas

PsA for the Dermatologist

Masterclasses in Dermatology

J. Merola, A. Gottlieb

The Window of Opportunity: Blockbuster Drugs, Opioids in Rheumatolog…

RheumNow

J. Cush

Sex Matters: Gender Differences in PsA Outcomes & Management

RheumNow

L. Eder

Diagnosing Psoriatic Arthritis for the Dermatologist: Making a Diffe…

Masterclasses in Dermatology

J. Merola, A. Gottlieb

2022 GRAPPA Treatment Recommendations

Laura Coates

EULAR® 2024 Insights: Reasons for Non-response to Treatments in Pati…

EULAR® 2024 Insights

F. Coşan

Axial Spondyloarthritis: What Are the New Treatment Guidelines and B…

Marina Magrey

GRAPPA 2024 Debate- Managing MSK Symptoms in PsO Patients: Who Shoul…

GRAPPA - Group for Research and Assessment of Psoriasis and Psoriatic Arthritis

F. Proft

Hard Decisions: HSV and RSV Update for Rheumatology

RheumNow

K. Winthrop

ACR Convergence 2023 Highlights: Two Studies: TAK-279 (Tyk2) in PsA …

RheumNow

G. Valenzuela

EULAR 2023 Insights: The Role of Observational Data When Studying Sa…

EULAR 2023 Insights

A. Strangfeld

Enthesitis & Dactylitis Management

RheumNow

A. Kavanaugh

Aims & Outcomes of Therapy in Ankylosing Spondylitis: What Are the A…

Keck School of Medicine of USC

N. Patel

Women in Rheumatology: Sex Differences in AxSpa

RheumNow

A. Ogdie

EULAR® 2024 Insights: Chronic Kidney Disease in Patients with Psoria…

EULAR® 2024 Insights

D. Gladman

Long COVID for the Rheumatologist

Cleveland Clinic Rheumatology

L. Calabrese